{"nct_id":"NCT04950764","title":"An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2021-09-17","start_date_type":"ACTUAL","primary_completion_date":"2025-02-24","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}